• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Rennee Rayburg, RPh, Discusses the Top Down Approach in Specialty Drug Management

Article

Renee Rayburg, RPh, Manager Clinical Pharmacy, OptumInsight, states that if providers narrowly focus on the traditional top down approach in specialty drug management they may miss out on opportunities for additional cost savings.

Renee Rayburg, RPh, Manager Clinical Pharmacy, OptumInsight, states that if providers narrowly focus on the traditional top down approach in specialty drug management they may miss out on opportunities for additional cost savings.

When providers only focus on their top drivers, they fail to recognize the impact specialty drug patients can have on pushing higher costs. Rayburg says, “When you look at a rare disease and a drug that might cost you a couple hundred thousand dollars a year, it’s going to make a difference if you have one or two of those in your population of people.”

Related Videos
Eileen Peng, PharmD, sitting for a video interview
Eva Svigethy, MD, PhD, and Ben Cohen, MD
ATS 2025
Bridgette J. Picou, LVN, ACLPN, The Well Project
Dr Gerard Criner
Emma Achola-Kothari, PhD
Dr Margrit Wiesendanger
Dr Emma Achola-Kothani
Marla Black Morgan, MD, Phoebe Neurology Associates
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.